Stay updated on Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.

Latest updates to the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2 with no visible changes to study details or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedThe update shows a revision from v3.4.0 to v3.4.1, with no changes to the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedAdded Show glossary and Hide glossary options and updated metadata labels to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. Removed the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.3%

- Check40 days agoChange DetectedRevision: v3.3.4 appears, replacing the prior Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check68 days agoChange Detected- Revision and footer policy updates: added Revision: v3.3.3, removed HHS Vulnerability Disclosure and Revision: v3.3.2; no changes to the study content or page functionality.SummaryDifference0.1%

- Check90 days agoChange DetectedRevision tag updated to v3.3.2; the previous v3.2.0 tag was removed.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Plus Chemotherapy in Operable Urothelial Cancer Clinical Trial page.